CS267399B1 - 2-arylimino-3-triphenylphosphonium indolates and method of their preparation - Google Patents

2-arylimino-3-triphenylphosphonium indolates and method of their preparation Download PDF

Info

Publication number
CS267399B1
CS267399B1 CS886605A CS660588A CS267399B1 CS 267399 B1 CS267399 B1 CS 267399B1 CS 886605 A CS886605 A CS 886605A CS 660588 A CS660588 A CS 660588A CS 267399 B1 CS267399 B1 CS 267399B1
Authority
CS
Czechoslovakia
Prior art keywords
triphenylphosphonium
arylimino
formula
indolates
preparation
Prior art date
Application number
CS886605A
Other languages
Czech (cs)
Other versions
CS660588A1 (en
Inventor
Jozef Rndr Csc Gonda
Pavol Prof Ing Drsc Kristian
Original Assignee
Gonda Jozef
Kristian Pavol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gonda Jozef, Kristian Pavol filed Critical Gonda Jozef
Priority to CS886605A priority Critical patent/CS267399B1/en
Publication of CS660588A1 publication Critical patent/CS660588A1/en
Publication of CS267399B1 publication Critical patent/CS267399B1/en

Links

Landscapes

  • Indole Compounds (AREA)

Abstract

Riešenie sa týká nových 2-arylimíno-3-trifenylfosfónium indolátov vzorca I. Zlúčeniny vzorca I sa priprávujú tak, ža sa na bromidy N- -aryl-N‘-(2-benzyltrifenylfosfónium) tiomočovín vzorca II pósobí tosylchloridom a látkami vybratými zo skupiny zahrnujúci alkalické hydroxidy a alkoholáty v prostředí nižších alkoholov v rozmedzí teplót 0 až 100 °C. Nové zlú­ čeniny sú využitelné pri výrobě biologicky účinných analógov indolových alkaloidov.The present invention relates to novel 2-arylimino-3-triphenylphosphonium of the indoles of formula I. Compounds of formula (I) are attributed to N- -aryl-N - (2-benzyltriphenylphosphonium) thiourea of formula II are caused by tosyl chloride and substances selected from the group consisting of alkali hydroxides and alcoholates in lower alcohols in a temperature range of 0 to 100 ° C. New bad The compounds are useful in the production of biologically effective indole alkaloid analogues.

Description

GONDA JOZEF RNDr. CSc., KRISTIAN PAVOL prof. ing. DrSc., KOŠICEGONDA JOZEF RNDr. CSc., KRISTIAN PAVOL prof. DrSc., KOŠICE

2-arylimíno-3-trífenylfosfónium indoláty a spósob ich popravy (57) Riešenie sa týká nových 2-arylimíno-3-trifenylfosfónium indolátov vzorca I. Zlúčeniny vzorca I sa priprávujú tak, ža sa na bromidy N-aryl-N‘-(2-benzyltrifenylfosfónium) tiomočovín vzorca II pósobí tosylchloridom a látkami vybratými zo skupiny zahrnujúci alkalické hydroxidy a alkoholáty v prostředí nižších alkoholov v rozmedzí teplot 0 až 100 °C. Nové zlúčeniny sú využitelné pri výrobě biologicky účinných analógov indolových alkaloidov.2-Arylimino-3-triphenylphosphonium indolates and process for their preparation (57) The solution relates to novel 2-arylimino-3-triphenylphosphonium indolates of formula I. The compounds of formula I are prepared by reacting N-aryl-N '- (2 -benzyltriphenylphosphonium) thioureas of formula II are treated with tosyl chloride and substances selected from the group consisting of alkali hydroxides and alcoholates in a lower alcohol environment in the temperature range from 0 to 100 ° C. The novel compounds are useful in the production of biologically active analogs of indole alkaloids.

CH2-P(C6Hs)3Br<CH 2 -P (C 6 H s) 3 Br <

NH-CS-NHNH-CS-NH

CS 267 399 BlCS 267 399 Bl

Vynález sa týká 2-arylimíno-3-trifenylfosfónium indolátov všeobecného vzorca IThe invention relates to 2-arylimino-3-triphenylphosphonium indolates of the formula I.

kde R značí H, 2-CH,, 4-CHj, 4-04,0, 3-CI a sposobu ich přípravy.wherein R denotes H, 2-CH 2, 4-CH 2, 4-04.0, 3-Cl and a process for their preparation.

Heterocyklické ylidy fosforu sú významnými medziproduktami pri syntéze biologických účinných látok [J. J. Pappas, E. Gantzer: Heterocycl. Chem. 6, 265 (1969)].Heterocyclic phosphorus ylides are important intermediates in the synthesis of biologically active substances [J. J. Pappas, E. Gantzer: Heterocycl. Chem. 6, 265 (1969)].

Stúdiom literatúry sa ukázalo, že 2-aryliiníno-3-trifenylfosfónium indoláty sú novými, v íiteratúre doteraz neopísanými zlúčeninami.A study of the literature has shown that 2-arylamino-3-triphenylphosphonium indolates are new compounds not yet described in the literature.

Podstata sposobu přípravy 2-arylimíno-3-trifenylfosfónium indolátov podfa vynálezu spočívá v tom, že sa na bromidy N-aryl-N‘-(2-benzyltrifenylfosfónium) tiomočovín všeobecného vzorca IIThe process for the preparation of 2-arylimino-3-triphenylphosphonium indolates according to the invention consists in applying to the bromides of N-aryl-N- (2-benzyltriphenylphosphonium) thioureas of the general formula II

CH2-P(C6H5)3 Br( )CH 2 -P (C 6 H 5 ) 3 Br ( )

NH-CS-NHNH-CS-NH

>R kde R značí H, 2-CH,, 4-CH,, 4-CH,0,3-C1, pósobí tosylchloridom za přítomnosti látok vybraných zo skupiny zahrnujúci alkalické hydroxidy alebo alkoholáty v prostředí nižších alkoholov v rozmedzí teplot 0-100 °C.> R where R denotes H, 2-CH 2, 4-CH 2, 4-CH, 0.3-Cl, is treated with tosyl chloride in the presence of substances selected from the group consisting of alkali hydroxides or alcoholates in a lower alcohol environment in the temperature range 0-100 ° C.

2-arylimíno-3-trifenylfosfónium indoláty pódia vynálezu predstavujú nový a reaktívny typ heterocyklického ylidu schopného vstupovať s karbonylovými zlúčeninami do Wittigovej reakcie za vzniku 2-arylimíno-3-alkylidén indo lov, ktoré sú využitelné pre syntézu biologicky účinných analógov indolových alkaloidov.The 2-arylimino-3-triphenylphosphonium indolates of the present invention are a novel and reactive type of heterocyclic ylide capable of reacting with carbonyl compounds into the Wittig reaction to form 2-arylimino-3-alkylidene indoles which are useful for the synthesis of biologically active analogs of indole alkaloids.

Predmet vynálezu ilustrujú ale neobmedzujú nasledovné příklady:The following examples illustrate but do not limit the invention:

Příklad 1Example 1

K suspenzii 5,83 g bromidu N-fenyl-N‘-(2-benzyltrifenylfosfónium) tiomočoviny v 50 ml metanolu sa přidá 0,66 g metanolátu sódneho. Reakčná zmes sa po 5 min. ochladí na 10 °C a v priebehu ďalších 5 min. sa přidá po dávkách 2,1 g tosylchloridu. K reakčnej zmesi sa potom přidá 1,3 g metanolátu sódneho. Roztok sa mieša pri 45-50 °C, kým sa tmavočervená farba přechodné vzniknutého ylidu nezmení na žltú. Reakčná zmes sa za horúca filtruje a nechá stáť cez noc. Vylúčený 2-fenylimíno-3-trifenylfosfónium indolát sa kryštalizuje zo zmesi chloroform-hexán; (fyz. chemické vlastnosti sú uvedené v tabul’ke 1).To a suspension of 5.83 g of N-phenyl-N- (2-benzyltriphenylphosphonium) thiourea bromide in 50 ml of methanol was added 0.66 g of sodium methanolate. The reaction mixture was stirred for 5 min. cooled to 10 ° C and over a further 5 min. 2.1 g of tosyl chloride are added portionwise. 1.3 g of sodium methanolate are then added to the reaction mixture. The solution was stirred at 45-50 ° C until the dark red color of the transient ylide formed turned yellow. The reaction mixture was filtered hot and allowed to stand overnight. The precipitated 2-phenylimino-3-triphenylphosphonium indolate is crystallized from chloroform-hexane; (physical chemical properties are given in Table 1).

Příklad 2Example 2

K suspenzii 5,97 g N-(4-tolyl)-N‘-(2-benzyltrifenylfosfónium) tiomočoviny v 100 ml etanolu ochladeného na 5 °C sa přidá za miešania 0,4 g hydroxidu sódneho v 20 ml etanolu. Po 10 min. sa pridajú 2 g pevného tosylchloridu a mieša sa ďalších 10 min. K reakčnej zmesi sa přidá nakoniec 0,9 g hydroxidu sódneho v 30 ml etanolu a zahrieva na 60-65 °C. Po 30 min. sa odfiltrujú nerozpustné soli a nechá stáť reakčná zmes cez noc. Vylúčený zvyšok sa kryštalizuje zo zmesi chloroform-hexán, resp. etanol.To a suspension of 5.97 g of N- (4-tolyl) -N- (2-benzyltriphenylphosphonium) thiourea in 100 ml of ethanol cooled to 5 ° C was added 0.4 g of sodium hydroxide in 20 ml of ethanol with stirring. After 10 min. 2 g of solid tosyl chloride are added and the mixture is stirred for a further 10 minutes. Finally, 0.9 g of sodium hydroxide in 30 ml of ethanol is added to the reaction mixture and heated to 60-65 ° C. After 30 min. insoluble salts are filtered off and the reaction mixture is allowed to stand overnight. The precipitated residue is crystallized from chloroform-hexane or ethanol.

Získané 2-arylimíno-3-trifenyífosfónium indoláty sú žité kryštalické látky (fyz.-chem. vlastnosti sú uvedené v tab. 1.).The obtained 2-arylimino-3-triphenylphosphonium indolates are lived crystalline substances (physical-chemical properties are given in Table 1).

Štruktúra zlúčenín bola dokázaná pomocou IČ, Ή NMR a 13C NMR spektier a hmotnostných spektier (tabul’ka 2 a 3).The structure of the compounds was proved by IR, 1 H NMR and 13 C NMR spectra and mass spectra (Tables 2 and 3).

Spektrálné meraniaSpectral measurements

IČ spektrá sa namerali na spektrofotometri Specord IR 75 (Carl Zeiss Jena). Ή NMR spektrá bolí nametané na 100 MHz spektrometri Tesla BS 567 a ,3C NMR (25,04 MHz) na spektrometri Tesla BS 567. Hmotnostné spektrá bolí snímané na spektrometri MS 902S (AEI ' Manchester) pri 70 eV.IR spectra were measured on a Specord IR 75 spectrophotometer (Carl Zeiss Jena). 1 H NMR spectra were measured on a Tesla BS 567 100 MHz spectrometer and 13 C NMR (25.04 MHz) on a Tesla BS 567 spectrometer. Mass spectra were read on an MS 902S spectrometer (AEI 'Manchester) at 70 eV.

Tabulka 1Table 1

Fyzikálno-chemické vlastnosti 2-arylimino-3-trifenylfosfónium indolátov všeobecného vzorca IIIPhysico-chemical properties of 2-arylimino-3-triphenylphosphonium indolates of formula III

Produkt vzorca III R’ Product of formula III R ' Vzorec (mol. hni.) Formula (mol. hni.) Výťažok (t. t.,°C) Yield (m.p., ° C) (NH) (NH) Vypočítané/zistené Calculated / found %C %C % H % H %N % N IIIa(!IIIa (! C„H„N,P C „H„ N, P 67 67 3198 3198 82,03 82.03 5,38 5.38 5,97 5.97 CH, CH, (468,5)“ (468.5) " 118-121 118-121 82,00 82.00 5,33 5.33 5,91 5.91 iflb iflb c„h27n2pc „h 27 n 2 p 43 43 3206 3206 82,13 82.13 5,64 5.64 5,80 5.80 2-CH3C0H4 2-CH 3 C 0 H 4 (482,6) (482.6) 76-78 76-78 82,19 82.19 5,72 5.72 5,75 5.75 lile lile c„h„n2pc „h„ n 2 p 71 71 3200 3200 82,13 82.13 5,64 5.64 5,80 5.80 4-CH,CTI, 4-CH, CTI, (48¾2 (48¾ 2 163-166 163-166 82,03 82.03 5,67 5.67 5,75 5.75 llkl^ llkl ^ C„H„N,OP C „H„ N, OP 76 76 3180 3180 79,49 79.49 5,46 5.46 5,62 5.62 4-CH.OC II 4-CH.OC II (498,6) (498.6) 141-143 141-143 79,53 79.53 5,39 5.39 5,60 5.60 lile lile CJL.CIN,!’ CJL.CIN ,! ’ 52 52 3203 3203 76,41 76.41 4,81 4.81 5,57 5.57 3-ClC6H4 3-ClC 6 H 4 ’fedi.o)2 'fedi.o) 2 164-166<!1)164-166 < ! 1 ) 76,41 76.41 4,81 4.81 5,57 5.57

I iI i

CS 267 399 Bl 3 4 CS 267 399 Bl 3 4

I ” Hmotnostně spektrum, ni/z (rel. int., %): 483 (M+, 16). 368 (53), 262 (95), 222 (98), 183 (100), 151 (41),131 (40).104 (86). .I ”Mass spectrum, ni / z (rel. Int.,%): 483 (M +, 16). 368 (53), 262 (95), 222 (98), 183 (100), 151 (41), 131 (40) .104 (86). .

b T. t. pre adičnú zlúčeninu s metanolom. volná báza je nestála. b M.p. for the methanol addition compound. the free base is unstable.

1 Hmotnostně spektrum, ni/z (rel. int., %); 499 (M + , 23), 384 (63), 262 (90), 238 (75), 222 (95), 199 (100), 107(61). 1 Mass spectrum, ni / z (rel. Int.,%); 499 (M + , 23), 384 (63), 262 (90), 238 (75), 222 (95), 199 (100), 107 (61).

Tabulka 2Table 2

Ή NMR spektr;! 2-arylimino-3-trifenylfosfónium indolátov všeobecného vzorca IIIΉ NMR spectrum; 2-arylimino-3-triphenylphosphonium indolates of formula III

4 4 Produkt Product H-7 (d) H-7 (d) H-6(dd) H-6 (dd) H-5 (dd) H-5 (dd) H-4(d) H-4 (d) P(CřH5 R-HP (C r H 5 RH Iné protony Other protons lila purple 6.90 6.90 6.73 6.73 6.63 6.63 6,25 6.25 7,05-7,90 7.05-7.90 5,05 s(NH) 5.05 s (NH) II Ib II Ib 7,00 7.00 6,81 6.81 6.63 6.63 6,25 6.25 7,35-7,80 7.35-7.80 5,43 s(NH) 2,18 s(CH) 5.43 s (NH) 2.18 s (CH) lile lile b b b b b b 6,30 6.30 7,51-7,88 7.51-7.88 3,79 s(NH) 3,38 s(CH) 3.79 s (NH) 3.38 s (CH) líkl líkl 6,98 6.98 6,75 6.75 6,58 6.58 6,23 6.23 7,43-7,88 7.43-7.88 4,91 s(NH) 3,72 s(CH) 4.91 s (NH) 3.72 s (CH)

b 6,33-7,03 m (H-7, H-6, H-5 sa prekrývajú s Η-Ar (4-tolyl). b 6.33-7.03 m (H-7, H-6, H-5 overlap with Η-Ar (4-tolyl).

Tabulka 3 ”C NMR spektra 2-arylimino-3-trifenylfosfónium indolátov všeobecného vzorca IIITable 3 "C NMR spectra of 2-arylimino-3-triphenylphosphonium indolates of formula III

C-atóm Xj(C,P),HzC-atom Xj (C, P), Hz lila purple IIIc IIIc Illd Illd 1’ 1 ' 123,1 123.1 124,1 124.1 123,1 123.1 (x=l) (x = l) (90,1) (90.1) (88,3) (88.3) (90,1) (90.1) 2’ 2 ’ 133,2 133.2 134,2 134.2 133,5 133.5 (x=2) (x = 2) (9,4) (9.4) (11,3) (11.3) (11,3) (11.3) 3’ 3 ' 129,7 129.7 129,7 129.7 129,5 129.5 (x=3) (x = 3) (11,3) (11.3) (11,1) (11.1) (11,3) (11.3) 4’ 4 ' 133,1 133.1 133,6 133.6 133,3 133.3 (x=4) (x = 4) (2,8) (2.8) (2,1) (2.1) (-) (-) 2 2 157,8 157.8 159,3 159.3 158,6 158.6 (x=2) (x = 2) (14,9) (14.9) (14,7) (14.7) (14,1) (14.1) 3 3 55,5 55.5 55,3 55.3 54,4 54.4 (x—1) (x — 1) (120) (120) (120) (120) (120,2) (120.2) 9 9 133,8 133.8 133,1 133.1 133,4 133.4 (x=2) (x = 2) (14,1) (14.1) (14,1) (14.1) (15) (15) 8 8 147,9 147.9 149,5 149.5 148,4 148.4 (x=3) (x = 3) (18,3) (18.3) (19,6) (19.6) (20,1) (20.1) 7 7 114,8 114.8 115,5 115.5 114,7 114.7 6 6 115,4 115.4 116,6 116.6 1.15,2 1.15.2 5 5 116,8 116.8 117,9 117.9 116,9 116.9 4 4 117,5 117.5 118,7 118.7 117,6 117.6 CH, CH, - 20,6 20.6 - CH,-N CH, -N - - - 10 ‘ 10 ‘ 142,5 142.5 140,1 140.1 135,9 135.9 11 11 115,8 115.8 116,6 116.6 135,9 135.9 12 12 127,6 127.6 129,1 129.1 113,5 113.5 13 13 118,2 118.2 128,6 128.6 152,3 152.3 14 14 - - -

Γ, 2', 3', 4’ - polohy benzenových kruhov v P(C6H5)r Γ, 2 ', 3', 4 '- positions of benzene rings in P (C 6 H 5 ) r

CS 267 399 BlCS 267 399 Bl

Claims (1)

PREDMET 1. 2-arylimíno-3-trifenylfosfónium indoláty všeobecného vzorca I li) . H^P(C6H5l3 ’ íil Γ (l) kde R značí H, 2-CH3, 4-CH3, 4-CH3O, 3-CI. 2. Spósob přípravy 2-arylimíno-3-trifenylfosfónium indolátov podfa bodu 1 vzorca I vyznačený tým, že sa na bromidy N-aryl-N‘-(2- VYNALEZU -benzyltrifenylfosfónium) tiomočovín obecného vzorca II (·) , ) CH2~PÍC6H5)3 Br’ ' txlL (HJ ^^XNH-CS-NH kde R značí H, 2-CH3, 4-CH3, 4-CH,O, 3-C1 posobí tosylchloridom za přítomnosti látok vyhřátých zo skupiny zahrnujúci alkalické hydroxidy a alkoholáty v prostředí nižších alkoholov v rozmedzí teplót 0-100 °CSUBJECT 1. 2-Arylimino-3-triphenylphosphonium indolates of formula I II). H 2 P (C 6 H 5 13 ' ) (I) wherein R is H, 2-CH 3 , 4-CH 3 , 4-CH 3 O, 3-Cl 2. Process for the preparation of 2-arylimino-3-triphenylphosphonium of indolates according to item 1 of formula I, characterized in that the bromides of N-aryl-N '- (2-INVENT-benzyltriphenylphosphonium) thioureas of the general formula II (·),) CH 2 -PIC 6 H 5 ) 3 Br''txlL ( HJ ^^ X is NH-CS-NH wherein R represents H, 2-CH3, 4-CH3, 4-CH, O, C1-3 subjected to the forces tosyl chloride in the presence of heated ingredients from the group comprising hydroxides and alcoholates of alkali in an lower alcohol in the temperature range 0-100 ° C Severografia, n. p., MOSTSeverography, n. P., MOST
CS886605A 1988-10-04 1988-10-04 2-arylimino-3-triphenylphosphonium indolates and method of their preparation CS267399B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS886605A CS267399B1 (en) 1988-10-04 1988-10-04 2-arylimino-3-triphenylphosphonium indolates and method of their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS886605A CS267399B1 (en) 1988-10-04 1988-10-04 2-arylimino-3-triphenylphosphonium indolates and method of their preparation

Publications (2)

Publication Number Publication Date
CS660588A1 CS660588A1 (en) 1989-06-13
CS267399B1 true CS267399B1 (en) 1990-02-12

Family

ID=5413504

Family Applications (1)

Application Number Title Priority Date Filing Date
CS886605A CS267399B1 (en) 1988-10-04 1988-10-04 2-arylimino-3-triphenylphosphonium indolates and method of their preparation

Country Status (1)

Country Link
CS (1) CS267399B1 (en)

Also Published As

Publication number Publication date
CS660588A1 (en) 1989-06-13

Similar Documents

Publication Publication Date Title
AU635369B2 (en) New (1-naphtyl)piperazine derivatives, process for preparing these and pharmaceutical compositions containing them
KR850000631B1 (en) Process for preparing piperidine derivatives
JP2018035194A (en) Modulators of prostacyclin (pgi2) receptor useful for treatment of disorders related to pgi2 receptor
JP2011515396A5 (en)
Safir et al. Experimental chemotherapy of trypanosomiasis. II. The preparation of compounds related to p-phenylenediguanidine
GB2058752A (en) N-propionylsarcosineanilides
CA2232090A1 (en) Selective .beta.3 adrenergic agonists
SU1091852A3 (en) Process for preparing derivatives of 2-aminomethyl-4,6-dihaloidophenol or their salts
CS267399B1 (en) 2-arylimino-3-triphenylphosphonium indolates and method of their preparation
SK138993A3 (en) Amidoalkyl - and imidoalkylpiperazines
US3383415A (en) 2-tertiary-aminomethyl-nu-(loweralkyl) anilines
Islip et al. Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. 4
FR2883876A1 (en) INDANYL-PIPERAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU2282622C2 (en) Bicyclic derivatives of guanidine and their therapeutic using
WO2022101453A1 (en) Compounds and methods for treating a cytokine-mediated disease
EP0356152B1 (en) Quaternary ammonium salts
US3398155A (en) 2, 6-dichloro-isonicotinamide derivatives and a method for their preparation
KR840002310B1 (en) Process for preparing guanidine compounds
US3972894A (en) Synthesis of oxindoles from anilines and β-thio carboxylic esters or amides
Gadekar et al. Hypotensive activity of some cyanoguanidines
CA1276639C (en) Aminobenzamide derivatives
PL95737B1 (en) METHOD OF MAKING NEW / TIAZOLILO-2 / ALKANOCARBONAMIDE
US6258976B1 (en) Process for the preparation of polyamines and polyamine derivatives
US3574194A (en) 1-alpha-ethyl - alpha - methyl-succinimido) -4-sulphonamidobenzene and related compounds
Jindal et al. Synthesis and β1-, β2-Adrenergic Receptor Binding Studies of 4-Acylaminosubstituted Phenoxypropanolamine and 5-Acylamino-substituted Naphthyloxypropanolamine Derivatives